ClinicalTrials.gov
public full text
Public Domain
Anti-Inflammatory Effects of Pioglitazone
There is increasing evidence that inflammation plays a role in progression and destabilization of atherosclerotic plaque. FDG-PET can visualize activated metabolic activity of inflammatory cells. It is possible that FDG-PET can detect atherosclerotic plaque inflammation and that FDG-PET can monitor the effect of pioglitazone on plaque inflammation.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Pioglitazone Decreases Visceral Fat Metabolism#801273
- Evaluation of [18F] PBR06 and PET as a Marker of Inflammation in Subjects With Neurological Conditions#889597
- Efficacy of Empagliflozin and Pioglitazone in Diabetic Patients With NAFLD#432857
- Pioglitazone and SGLT2 Inhibitors vs. DPP4 Inhibitors in Patients With Stroke#208403
- 9-month Study to Assess the Efficacy of Ofatumumab on Microglia in Patients With Relapsing Forms of Multiple Sclerosis#850391
Record · ID 1161931
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive